Published in
Wiley, Hepatology Research, 10(50), p. 1118-1127, 2020
DOI: 10.1111/hepr.13547
Links
Tools
Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment
Journal article published in 2020 by
Yuki Tahata,
Ryotaro Sakamori 
,
Ayako Urabe,
Ryoko Yamada,
Kazuyoshi Ohkawa ,
Naoki Hiramatsu,
Hideki Hagiwara,
Masahide Oshita,
Yasuharu Imai,
Takahiro Kodama ,
Hayato Hikita ,
Tomohide Tatsumi,
Tetsuo Takehara
,
Ayako Urabe,
Ryoko Yamada,
Kazuyoshi Ohkawa ,
Naoki Hiramatsu,
Hideki Hagiwara,
Masahide Oshita,
Yasuharu Imai,
Takahiro Kodama ,
Hayato Hikita ,
Tomohide Tatsumi,
Tetsuo Takehara
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 